Shawn Griffin

Health Sciences Assistant Clinical Professor

University of California, Irvine

United States

Research Interests

Explore related searches

Professors in United States Professors in Pharmacy Pharmacy professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shawn Griffin is an Assistant Clinical Professor in Health Sciences at the University of California, Irvine, USA. His research focuses on oncology pharmacy, including strategies for patient education in chemotherapy, treatment outcomes in lymphomas, and management of complications in stem cell transplantation. His recent publications highlight the intersection of clinical practice and research in advancing therapeutic approaches for hematology and oncology patients.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Nick Pannunzio

Assistant Professor

University of California, Irvine

UNITED STATES

View details

Lydia Benitez

University of Michigan

UNITED STATES

View details

Hannah Nam

Assistant Professor

University of California, Irvine

UNITED STATES

View details

Alexandre Chan

University of California, Irvine

UNITED STATES

View details

Ramy Hanna

UCLA Health

UNITED STATES

View details

Angela G. Fleischman

University of California, Irvine

UNITED STATES

View details

Susan O’Brien

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shawn Griffin

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT)

R-DA-EPOCH versus DA-EPOCH-R: Impact of Chemoimmunotherapy Sequencing on Treatment Outcomes in Patients with Diffuse Large B-cell Lymphoma

Time to complete oncology pharmacist tasks: A joint opinion of the Hematology/Oncology Pharmacy Association and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network

Comprehensive Framework for Oncology Pharmacist‐Led Parenteral Anticancer Therapy Patient Education: The Opinion of the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network

HyperCVAD versus pegaspargase‐containing regimens for Hispanic adults with newly diagnosed B‐cell acute lymphoblastic leukemia

Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection

Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience

Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd‐Generation Bruton Tyrosine Kinase Inhibitor‐Based Therapies

Eculizumab for Shiga‐toxin‐induced hemolytic uremic syndrome in adults with neurological involvement

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

Collaborators (7)

Nick Pannunzio

Lydia Benitez

Hannah Nam

Alexandre Chan

Ramy Hanna

Angela G. Fleischman

Susan O’Brien

Make your next move.